Castle Biosciences, Inc.CSTLNASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank88
5Y CAGR+45.5%
Studio
Year-over-Year Change

Cash generated from core business operations

5Y CAGR
+45.5%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
6.5x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$64.35M-0.8%
2024$64.87M+1253.0%
2023$-5.63M+86.5%
2022$-41.66M-119.4%
2021$-18.98M-292.4%
2020$9.87M+40.6%
2019$7.01M+157.1%
2018$-12.29M-0.5%
2017$-12.23M-